BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22137929)

  • 21. Valosin-containing protein gene mutations: clinical and neuropathologic features.
    Guyant-Maréchal L; Laquerrière A; Duyckaerts C; Dumanchin C; Bou J; Dugny F; Le Ber I; Frébourg T; Hannequin D; Campion D
    Neurology; 2006 Aug; 67(4):644-51. PubMed ID: 16790606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. UBQLN2 in familial amyotrophic lateral sclerosis in The Netherlands.
    van Doormaal PT; van Rheenen W; van Blitterswijk M; Schellevis RD; Schelhaas HJ; de Visser M; van der Kooi AJ; Veldink JH; van den Berg LH
    Neurobiol Aging; 2012 Sep; 33(9):2233.e7-2233.e8. PubMed ID: 22676852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathological consequences of VCP mutations on human striated muscle.
    Hübbers CU; Clemen CS; Kesper K; Böddrich A; Hofmann A; Kämäräinen O; Tolksdorf K; Stumpf M; Reichelt J; Roth U; Krause S; Watts G; Kimonis V; Wattjes MP; Reimann J; Thal DR; Biermann K; Evert BO; Lochmüller H; Wanker EE; Schoser BG; Noegel AA; Schröder R
    Brain; 2007 Feb; 130(Pt 2):381-93. PubMed ID: 16984901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No association of common VCP variants with sporadic frontotemporal dementia.
    Schumacher A; Friedrich P; Diehl J; Ibach B; Schoepfer-Wendels A; Mueller JC; Konta L; Laws SM; Kurz A; Foerstl H; Riemenschneider M
    Neurobiol Aging; 2009 Feb; 30(2):333-5. PubMed ID: 17618707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant valosin-containing protein causes a novel type of frontotemporal dementia.
    Schröder R; Watts GD; Mehta SG; Evert BO; Broich P; Fliessbach K; Pauls K; Hans VH; Kimonis V; Thal DR
    Ann Neurol; 2005 Mar; 57(3):457-61. PubMed ID: 15732117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a high-throughput microarray-based resequencing system for neurological disorders and its application to molecular genetics of amyotrophic lateral sclerosis.
    Takahashi Y; Seki N; Ishiura H; Mitsui J; Matsukawa T; Kishino A; Onodera O; Aoki M; Shimozawa N; Murayama S; Itoyama Y; Suzuki Y; Sobue G; Nishizawa M; Goto J; Tsuji S
    Arch Neurol; 2008 Oct; 65(10):1326-32. PubMed ID: 18852346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel peripherin gene (PRPH) mutation identified in one sporadic amyotrophic lateral sclerosis patient.
    Corrado L; Carlomagno Y; Falasco L; Mellone S; Godi M; Cova E; Cereda C; Testa L; Mazzini L; D'Alfonso S
    Neurobiol Aging; 2011 Mar; 32(3):552.e1-6. PubMed ID: 20363051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced ATPase activities as a primary defect of mutant valosin-containing proteins that cause inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia.
    Manno A; Noguchi M; Fukushi J; Motohashi Y; Kakizuka A
    Genes Cells; 2010 Aug; 15(8):911-22. PubMed ID: 20604808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational analysis of the VCP gene in Parkinson's disease.
    Majounie E; Traynor BJ; Chiò A; Restagno G; Mandrioli J; Benatar M; Taylor JP; Singleton AB
    Neurobiol Aging; 2012 Jan; 33(1):209.e1-2. PubMed ID: 21920633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two Australian families with inclusion-body myopathy, Paget's disease of bone and frontotemporal dementia: novel clinical and genetic findings.
    Kumar KR; Needham M; Mina K; Davis M; Brewer J; Staples C; Ng K; Sue CM; Mastaglia FL
    Neuromuscul Disord; 2010 May; 20(5):330-4. PubMed ID: 20335036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VCP gene analyses in Japanese patients with sporadic amyotrophic lateral sclerosis identify a new mutation.
    Hirano M; Nakamura Y; Saigoh K; Sakamoto H; Ueno S; Isono C; Mitsui Y; Kusunoki S
    Neurobiol Aging; 2015 Mar; 36(3):1604.e1-6. PubMed ID: 25457024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the Asian myopathy patients with VCP mutations.
    Shi Z; Hayashi YK; Mitsuhashi S; Goto K; Kaneda D; Choi YC; Toyoda C; Hieda S; Kamiyama T; Sato H; Wada M; Noguchi S; Nonaka I; Nishino I
    Eur J Neurol; 2012 Mar; 19(3):501-9. PubMed ID: 22040362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
    Weihl CC; Dalal S; Pestronk A; Hanson PI
    Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different dynamic movements of wild-type and pathogenic VCPs and their cofactors to damaged mitochondria in a Parkin-mediated mitochondrial quality control system.
    Kimura Y; Fukushi J; Hori S; Matsuda N; Okatsu K; Kakiyama Y; Kawawaki J; Kakizuka A; Tanaka K
    Genes Cells; 2013 Dec; 18(12):1131-43. PubMed ID: 24215292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening UBQLN-2 in French frontotemporal lobar degeneration and frontotemporal lobar degeneration-amyotrophic lateral sclerosis patients.
    Lattante S; Le Ber I; Camuzat A; Pariente J; Brice A; Kabashi E;
    Neurobiol Aging; 2013 Aug; 34(8):2078.e5-6. PubMed ID: 23582661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis.
    Weihl CC; Baloh RH; Lee Y; Chou TF; Pittman SK; Lopate G; Allred P; Jockel-Balsarotti J; Pestronk A; Harms MB
    Neuromuscul Disord; 2015 Apr; 25(4):289-96. PubMed ID: 25617006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget's disease of bone and frontotemporal dementia.
    Stojkovic T; Hammouda el H; Richard P; López de Munain A; Ruiz-Martinez J; Camaño P; Laforêt P; Pénisson-Besnier I; Ferrer X; Lacour A; Lacomblez L; Claeys KG; Maurage CA; Fardeau M; Eymard B
    Neuromuscul Disord; 2009 May; 19(5):316-23. PubMed ID: 19364651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in UBQLN2 are rare in French amyotrophic lateral sclerosis.
    Millecamps S; Corcia P; Cazeneuve C; Boillée S; Seilhean D; Danel-Brunaud V; Vandenberghe N; Pradat PF; Le Forestier N; Lacomblez L; Bruneteau G; Camu W; Brice A; Meininger V; LeGuern E; Salachas F
    Neurobiol Aging; 2012 Apr; 33(4):839.e1-3. PubMed ID: 22169395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation analysis of the optineurin gene in familial amyotrophic lateral sclerosis.
    Solski JA; Williams KL; Yang S; Nicholson GA; Blair IP
    Neurobiol Aging; 2012 Jan; 33(1):210.e9-10. PubMed ID: 22015311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His.
    van der Zee J; Pirici D; Van Langenhove T; Engelborghs S; Vandenberghe R; Hoffmann M; Pusswald G; Van den Broeck M; Peeters K; Mattheijssens M; Martin JJ; De Deyn PP; Cruts M; Haubenberger D; Kumar-Singh S; Zimprich A; Van Broeckhoven C
    Neurology; 2009 Aug; 73(8):626-32. PubMed ID: 19704082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.